Fluxergy Inc.
Fluxergy Inc. is a company focused on revolutionizing point-of-care testing with its innovative, multimodal platform. The company aims to bring laboratory capabilities directly to patients, offering rapid, accurate, and cost-effective diagnostic solutions. Fluxergy's technology is designed to streamline testing processes, making it accessible and viable for clinical and community-level applications. Their mission is to enhance biosecurity and improve diagnostic efficiency across various sectors, including clinical diagnostics and veterinary medicine.
Industries
Nr. of Employees
medium (51-250)
Fluxergy Inc.
30 Fairbanks, Suite 110, Irvine, CA 92618, United States
Patents
Device for analyzing a fluid sample and use of test card with same
2022-06-28 • US-11371091-B2
View DetailsApparatus and method for image analysis of a fluid sample undergoing a polymerase chain reaction (PCR)
2019-12-31 • US-10519493-B2
View Details
Device for analyzing a fluid sample and use of test card with same
2022-06-28 • US-11371091-B2
View DetailsApparatus and method for image analysis of a fluid sample undergoing a polymerase chain reaction (PCR)
2019-12-31 • US-10519493-B2
View DetailsProducts
Desktop multimodal point-of-care analyzer
Desktop analyzer designed to run molecular, immunoassay, cytometry, and electrochemical assays from single-use microfluidic test cartridges for point-of-care settings.
Single‑use microfluidic test cartridge
Disposable microfluidic cartridge designed to host multiplex and multimodal assays, containing preconfigured fluidics and reagent/reaction zones for automated point-of-care testing.
Point-of-care instrument control and results software
Software for starting and monitoring assay runs, managing instrument workflows, and viewing/exporting results at the point of care.
RT‑PCR point-of-care test kit (CE‑IVD) for SARS‑CoV‑2
Sample-to-answer RT‑PCR test kit validated in clinical studies and CE‑IVD marked for SARS‑CoV‑2 detection on the point-of-care analyzer with ~1 hour turnaround.
Multiplex respiratory PCR panel (Influenza A/B, RSV, SARS‑CoV‑2)
Multiplex panel for simultaneous detection of common respiratory viruses on a single cartridge, intended for on-site clinical respiratory testing.
Veterinary molecular assay kits (e.g., Streptococcus equi, EHV‑1)
Rapid molecular assay kits for veterinary pathogens optimized for stall-side or on-site testing to support biosecurity and outbreak response in equine and other veterinary contexts.
Desktop multimodal point-of-care analyzer
Desktop analyzer designed to run molecular, immunoassay, cytometry, and electrochemical assays from single-use microfluidic test cartridges for point-of-care settings.
Single‑use microfluidic test cartridge
Disposable microfluidic cartridge designed to host multiplex and multimodal assays, containing preconfigured fluidics and reagent/reaction zones for automated point-of-care testing.
Point-of-care instrument control and results software
Software for starting and monitoring assay runs, managing instrument workflows, and viewing/exporting results at the point of care.
RT‑PCR point-of-care test kit (CE‑IVD) for SARS‑CoV‑2
Sample-to-answer RT‑PCR test kit validated in clinical studies and CE‑IVD marked for SARS‑CoV‑2 detection on the point-of-care analyzer with ~1 hour turnaround.
Multiplex respiratory PCR panel (Influenza A/B, RSV, SARS‑CoV‑2)
Multiplex panel for simultaneous detection of common respiratory viruses on a single cartridge, intended for on-site clinical respiratory testing.
Veterinary molecular assay kits (e.g., Streptococcus equi, EHV‑1)
Rapid molecular assay kits for veterinary pathogens optimized for stall-side or on-site testing to support biosecurity and outbreak response in equine and other veterinary contexts.
Expertise Areas
- Point-of-care diagnostic platform development
- Molecular diagnostics (RT‑PCR/qPCR) and multiplex panels
- Microfluidic single‑use cartridge manufacturing and scale-up
- Analytical and clinical assay validation (LOD, cross-reactivity, sensitivity/specificity)
Key Technologies
- RT‑PCR / qPCR
- Microfluidic single‑use test cartridges
- Multiplex PCR panels
- Sample‑to‑answer automation
Key People
Tej Patel
President and Co-Founder
Ryan Revilla
Vice President and Co-Founder
Jonathan Tu
CFO and Co-Founder
Bernd Schnell
General Manager - Europe
Pramod Naranatt
Associate Director, Molecular Assay Development
Robert Kinz
General Counsel, Head of Strategic Alliances
Tej Patel
President and Co-Founder
Ryan Revilla
Vice President and Co-Founder
Jonathan Tu
CFO and Co-Founder
Bernd Schnell
General Manager - Europe
Pramod Naranatt
Associate Director, Molecular Assay Development
Robert Kinz
General Counsel, Head of Strategic Alliances
News & Updates
Fluxergy Co-Founder and CEO Tej Patel interviews Alan Ayers on the role of point-of-care testing in urgent care settings.
An article discussing Fluxergy's advancements in rapid PCR technology.
An article highlighting the need for improved testing during flu seasons.
An article exploring the challenges in adopting point-of-care testing technologies.
An external article summarizing digital health news and funding updates, including Fluxergy's activities.
Fluxergy has acquired employees, assets, and licensed technology from InnaMed, Inc, to enhance its diagnostic capabilities.
Fluxergy Co-Founder and CEO Tej Patel interviews Alan Ayers on the role of point-of-care testing in urgent care settings.
An article discussing Fluxergy's advancements in rapid PCR technology.
An article highlighting the need for improved testing during flu seasons.
An article exploring the challenges in adopting point-of-care testing technologies.
An external article summarizing digital health news and funding updates, including Fluxergy's activities.
Fluxergy has acquired employees, assets, and licensed technology from InnaMed, Inc, to enhance its diagnostic capabilities.